Dario Sangiolo

3.5k total citations
76 papers, 2.2k citations indexed

About

Dario Sangiolo is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Dario Sangiolo has authored 76 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 60 papers in Oncology, 43 papers in Immunology and 15 papers in Molecular Biology. Recurrent topics in Dario Sangiolo's work include CAR-T cell therapy research (37 papers), Immune Cell Function and Interaction (30 papers) and Immunotherapy and Immune Responses (21 papers). Dario Sangiolo is often cited by papers focused on CAR-T cell therapy research (37 papers), Immune Cell Function and Interaction (30 papers) and Immunotherapy and Immune Responses (21 papers). Dario Sangiolo collaborates with scholars based in Italy, United States and China. Dario Sangiolo's co-authors include Massimo Aglietta, Giovanni Grignani, Loretta Gammaitoni, Valeria Leuci, Fabrizio Carnevale‐Schianca, Giulia Mesiano, Lorenzo D’Ambrosio, Ymera Pignochino, Franca Fagioli and Wanda Piacibello and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Dario Sangiolo

75 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Dario Sangiolo Italy	25	1.4k	1.1k	549	442	200	76	2.2k
Lucas Ferrari de Andrade United States	16	1.6k 1.1×	1.6k 1.5×	666 1.2×	328 0.7×	217 1.1×	29	2.6k
Sydney Gordon United States	8	1.4k 1.0×	1.7k 1.6×	740 1.3×	293 0.7×	210 1.1×	10	2.8k
Jeffrey J. Wallin United States	28	1.2k 0.9×	1.1k 1.0×	829 1.5×	483 1.1×	228 1.1×	60	2.8k
Riccardo Danielli Italy	22	1.4k 1.0×	1.0k 1.0×	728 1.3×	621 1.4×	133 0.7×	45	2.4k
Jason Madore Australia	25	1.6k 1.2×	1.0k 0.9×	756 1.4×	459 1.0×	320 1.6×	32	2.5k
Colm R. Duffy United States	4	1.6k 1.2×	1.1k 1.0×	514 0.9×	394 0.9×	209 1.0×	11	2.3k
Dongkyoon Kim United States	9	1.3k 0.9×	1.3k 1.2×	909 1.7×	562 1.3×	424 2.1×	14	2.5k
Stefania Canè Italy	23	698 0.5×	768 0.7×	619 1.1×	197 0.4×	310 1.6×	39	2.0k
Danny N. Khalil United States	14	950 0.7×	637 0.6×	410 0.7×	274 0.6×	204 1.0×	40	1.6k
Maria Pia Pistillo Italy	25	804 0.6×	1.1k 1.0×	580 1.1×	213 0.5×	279 1.4×	77	2.1k

Countries citing papers authored by Dario Sangiolo

Since Specialization

Citations

This map shows the geographic impact of Dario Sangiolo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dario Sangiolo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dario Sangiolo more than expected).

Fields of papers citing papers by Dario Sangiolo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dario Sangiolo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dario Sangiolo. The network helps show where Dario Sangiolo may publish in the future.

Co-authorship network of co-authors of Dario Sangiolo

This figure shows the co-authorship network connecting the top 25 collaborators of Dario Sangiolo. A scholar is included among the top collaborators of Dario Sangiolo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dario Sangiolo. Dario Sangiolo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Olivero, Martina, Riccardo Taulli, Francesca Bersani, et al.. (2025). Shifting Shapes: The Endothelial-to-Mesenchymal Transition as a Driver for Cancer Progression. International Journal of Molecular Sciences. 26(13). 6353–6353. 2 indexed citations

Merlini, Alessandra, Dario Sangiolo, Paolo Bironzo, et al.. (2024). Epigenetic determinants in soft tissue sarcomas: molecular mechanisms and therapeutic targets. Expert Opinion on Therapeutic Targets. 28(1-2). 17–28. 2 indexed citations

Petti, Consalvo, et al.. (2024). Repurposing anti-mesothelin CAR-NK immunotherapy against colorectal cancer. Journal of Translational Medicine. 22(1). 1100–1100. 4 indexed citations

Leuci, Valeria, Annamaria Massa, Ramona Rotolo, et al.. (2024). Three-dimensional dynamics of mesothelin-targeted CAR.CIK lymphocytes against ovarian cancer peritoneal carcinomatosis. Cancer Immunology Immunotherapy. 74(1). 6–6. 2 indexed citations

Paruzzo, Luca, et al.. (2023). Predictive Factors in Metastatic Melanoma Treated with Immune Checkpoint Inhibitors: From Clinical Practice to Future Perspective. Cancers. 16(1). 101–101. 3 indexed citations

Pignochino, Ymera, Giovanni Crisafulli, G Giordano, et al.. (2021). PARP1 Inhibitor and Trabectedin Combination Does Not Increase Tumor Mutational Burden in Advanced Sarcomas—A Preclinical and Translational Study. Cancers. 13(24). 6295–6295. 2 indexed citations

Giordano, G, Alessandra Merlini, Giulio Ferrero, et al.. (2021). EphA2 Expression in Bone Sarcomas: Bioinformatic Analyses and Preclinical Characterization in Patient-Derived Models of Osteosarcoma, Ewing’s Sarcoma and Chondrosarcoma. Cells. 10(11). 2893–2893. 20 indexed citations

Rotolo, Ramona, et al.. (2021). Cellular Immunotherapy Targeting Cancer Stem Cells: Preclinical Evidence and Clinical Perspective. Cells. 10(3). 543–543. 19 indexed citations

Denaro, Nerina, Danilo Galizia, Loretta Gammaitoni, et al.. (2021). P-89 Cytokines behaviour during nivolumab treatment. A subgroup analysis of NIVACTOR study. Oral Oncology. 118. 8–8. 1 indexed citations

10.

Pellegrino, Benedetta, Antonino Musolino, Alba Llop‐Guevara, et al.. (2020). Homologous Recombination Repair Deficiency and the Immune Response in Breast Cancer: A Literature Review. Translational Oncology. 13(2). 410–422. 50 indexed citations

11.

Sanlorenzo, Martina, Igor Vujic, Mauro Novelli, et al.. (2018). BRAF and MEK Inhibitors Increase PD-1-Positive Melanoma Cells Leading to a Potential Lymphocyte-Independent Synergism with Anti–PD-1 Antibody. Clinical Cancer Research. 24(14). 3377–3385. 30 indexed citations

12.

D’Ambrosio, Lorenzo, et al.. (2018). Next generation immune-checkpoints for cancer therapy. Journal of Thoracic Disease. 10(S13). S1581–S1601. 52 indexed citations

13.

Gallo, Susanna, et al.. (2017). Treating breast cancer with cell-based approaches: an overview. Expert Opinion on Biological Therapy. 17(10). 1255–1264. 4 indexed citations

14.

Milani, Andrea, Dario Sangiolo, Massimo Aglietta, & Giorgio Valabrega. (2014). Recent advances in the development of breast cancer vaccines. SHILAP Revista de lepidopterología. 5 indexed citations

15.

Milani, Andrea, Dario Sangiolo, Filippo Montemurro, Massimo Aglietta, & Giorgio Valabrega. (2013). Active immunotherapy in HER2 overexpressing breast cancer: current status and future perspectives. Annals of Oncology. 24(7). 1740–1748. 71 indexed citations

16.

Gammaitoni, Loretta, Lidia Giraudo, Valeria Leuci, et al.. (2013). Effective Activity of Cytokine-Induced Killer Cells against Autologous Metastatic Melanoma Including Cells with Stemness Features. Clinical Cancer Research. 19(16). 4347–4358. 80 indexed citations

17.

Pignochino, Ymera, Carmine Dell’Aglio, Marco Basiricò, et al.. (2013). The Combination of Sorafenib and Everolimus Abrogates mTORC1 and mTORC2 Upregulation in Osteosarcoma Preclinical Models. Clinical Cancer Research. 19(8). 2117–2131. 91 indexed citations

18.

Leuci, Valeria, Giulia Mesiano, Loretta Gammaitoni, et al.. (2011). Transient proteasome inhibition as a strategy to enhance lentiviral transduction of hematopoietic CD34+ cells and T lymphocytes: Implications for the use of low viral doses and large-size vectors. Journal of Biotechnology. 156(3). 218–226. 13 indexed citations

19.

Sangiolo, Dario, et al.. (2007). Lentiviral vector conferring resistance to mycophenolate mofetil and sensitivity to ganciclovir for in vivo T-cell selection. Gene Therapy. 14(21). 1549–1554. 12 indexed citations

20.

Perissinotto, Eliana, Giuliana Cavalloni, Francesco Leone, et al.. (2005). Involvement of Chemokine Receptor 4/Stromal Cell–Derived Factor 1 System during Osteosarcoma Tumor Progression. Clinical Cancer Research. 11(2). 490–497. 105 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact